Marshall Wace
TXMD icon

Marshall Wace’s TherapeuticsMD TXMD Stock Holding History

Marshall Wace’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,230
Closed -$1.03M – 1173
2016
Q1 		$1.03M Buy
+3,230
New +$1.1M 0.01% 701
2015
Q2 		– Sell
-1,431
Closed -$433K – 1053
2015
Q1 		$433K Buy
+1,431
New +$349K 0.01% 690
2014
Q4 		– Sell
-447
Closed -$104K – 974
2014
Q3 		$104K Buy
+447
New +$113K ﹤0.01% 829

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Marshall Wace's TXMD Position: Q2 2016 in Review

Marshall Wace sold out of TherapeuticsMD (TXMD) in Q2 2016, closing a stake of 3,230 shares — an estimated $1.03M sold.

Marshall Wace first reported a position in TXMD in Q3 2014 and held it in 3 quarters. The position peaked at $1.03M in Q1 2016. 123 funds tracked by Wall St. Rank hold TXMD as of Q2 2016.

  • Marshall Wace reported no remaining TherapeuticsMD position as of Q2 2016 after selling out during the quarter.
  • Marshall Wace sold 3,230 TherapeuticsMD shares in Q2 2016, an estimated $1.03M.
  • Marshall Wace first reported a position in TherapeuticsMD in Q3 2014 and held it in 3 quarters.
  • Marshall Wace's TherapeuticsMD position peaked at $1.03M in Q1 2016.
  • 123 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2016.

Based on Marshall Wace's 13F filing for Q2 2016, filed 12 Aug 2016.